Conversely, APTT prolongation may be related to the transient increased levels of antiphospholipid antibodies, a situation encountered during viral infections [139], including COVID-19 [10, 140–143], or when CRP is high [138], thus leading to a risk of heparin underdosage. This evidence concerns the gene CRP and COVID-19.